AwardedPOLGoods
Preparat rekombinowanego ludzkiego insulinopodobnego czynnika wzrostu - 1 (mekasermina); znak postępowania: ZZP.ZP.411.18.2025
- Published
- Published 27 February 2025
- Deadline
- Closed 18 March 2025
Overview
Przedmiotem zamówienia jest dostawa preparatu rekombinowanego ludzkiego insulinopodobnego czynnika wzrostu - 1 (mekasermina) do podawania w ogólnie dostępnych strzykawkach o małej pojemności i dużej dokładności: - fiolka/ampułka o pojemności < 50 mg
Key details
- Country
- POL
- Status
- Awarded
- Category
- Goods
- Procedure
- Open
- Published
- 27 February 2025
- Deadline
- Closed
Pituitary, hypothalamic hormones and analogues
Award outcome
- Awarded value
- PLN 6,527,621
- Award date
- 7 May 2025
- Contract period
- — → 1 July 2026
- NEUCA S.A
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
27 October 2025
Contract Notice
13 March 2025
Contract Notice
27 February 2025
Contracting authority
Instytut "Pomnik - Centrum Zdrowia Dziecka"
Procuring entityWarszawa, POL
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.